BR9507553A - Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída) - Google Patents

Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída)

Info

Publication number
BR9507553A
BR9507553A BR9507553A BR9507553A BR9507553A BR 9507553 A BR9507553 A BR 9507553A BR 9507553 A BR9507553 A BR 9507553A BR 9507553 A BR9507553 A BR 9507553A BR 9507553 A BR9507553 A BR 9507553A
Authority
BR
Brazil
Prior art keywords
heterosubstituted
antimicrobials
starch
new quinoline
quinoline
Prior art date
Application number
BR9507553A
Other languages
English (en)
Inventor
Thomas Prosser Demuth
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9507553A publication Critical patent/BR9507553A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9507553A 1994-04-28 1995-04-11 Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída) BR9507553A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/235,003 US5646163A (en) 1992-10-30 1994-04-28 Quinolone 5-(N-heterosubstituted amino) antimicrobials
PCT/US1995/004495 WO1995029894A1 (en) 1994-04-28 1995-04-11 Novel quinolone 5-(n-heterosubstituted amino) antimicrobials

Publications (1)

Publication Number Publication Date
BR9507553A true BR9507553A (pt) 1997-08-05

Family

ID=22883653

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9507553A BR9507553A (pt) 1994-04-28 1995-04-11 Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída)

Country Status (11)

Country Link
US (1) US5646163A (pt)
EP (1) EP0757675A1 (pt)
JP (1) JPH09512549A (pt)
KR (1) KR100244992B1 (pt)
CN (1) CN1157611A (pt)
AU (1) AU2246695A (pt)
BR (1) BR9507553A (pt)
CA (1) CA2188918A1 (pt)
FI (1) FI964318A (pt)
NO (1) NO964533L (pt)
WO (1) WO1995029894A1 (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100728797B1 (ko) * 2000-09-11 2007-06-19 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 티로신 키나제 억제제로서의 퀴놀리논 유도체
MXPA06001645A (es) * 2003-08-12 2006-05-12 Achillion Pharmaceuticals Inc Isotiazoloquinolonas y compuestos relacionados como agentes anti-infecciosos.
BRPI0413964B8 (pt) 2003-09-10 2021-05-25 Kyorin Seiyaku Kk ácido derivado do ácido carboxílico quinolona, sua composição e agente antibacterial
JP2008509909A (ja) * 2004-08-11 2008-04-03 ウィリアムスバーグ・ホールディングス・エルエルシー 心毒性のない医薬化合物
PE20060489A1 (es) 2004-08-13 2006-06-19 Schering Plough Ltd Formulacion farmaceutica que comprende un antibiotico, un triazol y un corticosteroide
EP1802306A2 (en) * 2004-09-17 2007-07-04 Cylene Pharmaceuticals, Inc. Quinolone analog as cell proliferation inhibitors
US7652134B2 (en) * 2004-09-17 2010-01-26 Cylene Pharmaceuticals, Inc. Methods for converting quinolone esters into quinolone amides
EP1809639B1 (en) * 2004-11-11 2009-10-14 Achillion Pharmaceuticals, Inc. 8a, 9-dihydro-4a-h-isothiazolo[5,4-b] quinoline-3, 4-diones and related compounds as anti-infective agents
US7659399B2 (en) * 2005-01-05 2010-02-09 Achillion Pharmaceuticals, Inc. 1-thia-2,4a-diaza-cyclopenta[b]napththalene-3,4-diones and related compounds as anti-infective agents
US7199128B2 (en) 2005-02-02 2007-04-03 Achillion Pharmaceuticals, Inc. 8-N-substituted-2H-isothiazolo[5,4-b]quinolizine-3,4-diones and related compounds as antiinfective agents
MX2007009895A (es) * 2005-02-16 2007-10-03 Achillion Pharmaceuticals Inc Nuevas isotiazoloquinolonas y compuestos relacionados como agentes anti-infecciosos.
US8044204B2 (en) * 2005-07-27 2011-10-25 Achillion Pharmaceuticals, Inc. 8-methoxy-9H-isothiazolo[5,4-b]quinoline-3,4-diones and related compounds as anti-infective agents
PT1928887E (pt) * 2005-08-05 2015-02-12 Senhwa Biosciences Inc Métodos de preparação de análogos de quinolona
CL2007003332A1 (es) * 2006-11-24 2008-06-20 Actelion Pharmaceuticals Ltd Compuestos derivados de heterociclos condensados; compuestos intermediarios; composicion farmaceutica; y uso en la prevencion o tratamiento de infecciones bacterianas.
US8183236B2 (en) * 2007-04-12 2012-05-22 University Of Southern California Compounds with HIV-1 integrase inhibitory activity and use thereof as anti-HIV/AIDS therapeutics
JP5322927B2 (ja) * 2007-05-24 2013-10-23 杏林製薬株式会社 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2145891A1 (en) * 2008-07-09 2010-01-20 Vetoquinol S.A. 9-substituted-5-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials
NZ595448A (en) * 2009-04-03 2013-01-25 Achillion Pharmaceuticals Inc Hydroxythienoquinolones and related compounds as anti-infective agents
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
CN102725274A (zh) 2009-10-16 2012-10-10 Rib-X制药公司 抗微生物化合物和其制备和使用方法
TWI612048B (zh) * 2009-10-16 2018-01-21 梅林塔療法公司 抗微生物性化合物,及製法及其用途
DK2488532T3 (en) 2009-10-16 2018-08-13 Melinta Therapeutics Inc ANTIMICROBIAL COMPOUNDS AND PROCEDURES FOR PREPARING AND USING THE SAME
KR20160070066A (ko) 2013-09-09 2016-06-17 멜린타 테라퓨틱스, 인크. 항균 화합물, 및 이의 제조 방법 및 이용 방법
EP3038623A4 (en) 2013-09-09 2017-04-19 Melinta Therapeutics, Inc. Antimicrobial compounds and methods of making and using the same
US10947237B2 (en) 2015-03-11 2021-03-16 BioVersys AG Antimicrobial compounds and methods of making and using the same
WO2017193016A1 (en) 2016-05-06 2017-11-09 Melinta Therapeutics, Inc. Antimicrobials and methods of making and using same

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
IE58742B1 (en) * 1984-07-20 1993-11-05 Warner Lambert Co Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7h-pyrido[1,2,3-de] [1,4]benzoxauine-6-carboxylic acids; sibstituted-5-amino-6-6fluoro-4-oxo.1,4-dihydroquinoline-3 carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1.8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds
US4822801A (en) * 1984-07-20 1989-04-18 Warner-Lambert Company 4-oxo-1,4-dihydroquinoline-3-carboxylic acid derivative as antibacterial agents
US4623650A (en) * 1984-12-06 1986-11-18 Pfizer Inc. Antibiotic derivatives of 7-phenyl-1,4-dihydro-4-oxo-3-quinolinecarboxylic acids
AU594983B2 (en) * 1985-10-29 1990-03-22 Dainippon Pharmaceutical Co. Ltd. Novel quinoline derivatives and processes for preparation thereof
US4954507A (en) * 1986-10-08 1990-09-04 Bristol-Myers Company 1-tertiary-alkyl-substituted naphthyridine carboxylic acid antibacterial agents
DE3711193A1 (de) * 1987-04-02 1988-10-13 Bayer Ag 5-substituierte chinolon- und naphthyridoncarbonsaeure-derivate
AU609974B2 (en) * 1988-05-18 1991-05-09 Warner-Lambert Company Improved process for the preparation of 5-amino-7- (substituted amino)-quinoline-3-carboxylic acids
JP2664950B2 (ja) * 1988-08-31 1997-10-22 日本電気株式会社 入出力処理装置
US4945160A (en) * 1988-11-22 1990-07-31 Warner-Lambert Company Preparation of certain 7-substituted quinolones
ES2147721T3 (es) * 1990-04-18 2000-10-01 Procter & Gamble Pharma Quinolonil lactamas antimicrobianas.
SK37594A3 (en) * 1991-10-01 1995-02-08 Procter & Gamble Pharma Method of preparation of antimicrobial quinolonyl lactams
EG20543A (en) * 1992-10-30 1999-07-31 Procter & Gamble Process for preparing of novel antimicrobial -5- (n-heterosubstituted amino) quinolones

Also Published As

Publication number Publication date
WO1995029894A1 (en) 1995-11-09
KR100244992B1 (ko) 2000-03-02
FI964318A (fi) 1996-12-23
US5646163A (en) 1997-07-08
KR970702849A (ko) 1997-06-10
CN1157611A (zh) 1997-08-20
NO964533D0 (no) 1996-10-25
EP0757675A1 (en) 1997-02-12
NO964533L (no) 1996-12-23
FI964318A0 (fi) 1996-10-25
JPH09512549A (ja) 1997-12-16
CA2188918A1 (en) 1995-11-09
AU2246695A (en) 1995-11-29

Similar Documents

Publication Publication Date Title
BR9507553A (pt) Novos antimicrobianos de quinolina 5-(amido n- heterossubstituída)
DE69818442D1 (de) Substituierte 3-cyanochinoline
ATE289994T1 (de) Chinolin-derivate
DE59510638D1 (de) Offsetdruckmaschine
ID25774A (id) Celana sekali pakai tanpa pengikat
NO961887L (no) -adrenergiske agonister
DE69410806D1 (de) Klappbare Schöpfkelle
BR9509793A (pt) Derivados de tiofeneno
FI970110A (fi) Helico-bakteerin vastaisia heterosyklisiä atsolonijohdannaisia
IS4321A (is) Nýjar díalkoxý-pýridínýl-bensimidasólafleiður
BR9507892A (pt) Novos derivados de diamino-metilideno
DE69634183D1 (de) Substituierte Heterocyclen
KR950033309U (ko) 줄연장
DE69824255D1 (de) Deformylase
BR9506618A (pt) Derivados de difeniloxazolinas
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
DE69711853D1 (de) Pyridincarboxamid-derivate
FI955818A (fi) Uudet heterosykliset amidit
DE59505744D1 (de) Scharnier
KR950031850U (ko) 피조개 채취기
BR9506613A (pt) Derivados de feniltio-oxazolinas
DE59506932D1 (de) Scharnier
BR9508450A (pt) Derivados de n-alcóxi-amidina
PT8992T (pt) Triangulo de pre-sinalizacao
KR950023498U (ko) 경첩

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal